Drug Type Small molecule drug |
Synonyms THRX 109156, THRX109156 |
Target |
Action agonists |
Mechanism β2-adrenergic receptor agonists(Beta-2 adrenergic receptor agonists) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhasePendingPreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC37H45N5O6 |
InChIKeyFUIVIZCFQUCDAW-XIFFEERXSA-N |
CAS Registry743460-42-6 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Pulmonary Disease, Chronic Obstructive | Preclinical | United States | 28 Jan 2015 |